Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PRVA · against 348 other Healthcare companies of similar size
Ranked #185 of 349 · scores higher than 47% of peers · safety percentile 50
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)36 peers with a safety percentile of 40–49, including PRVA · Click a bar to see the companies
A mix: stronger debt / equity, but weaker beta and current ratio than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | PRVA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 337 reported | 0.01× | 0.23× | 89% | 33% | |
| BetaLower is better · 334 reported | 0.88 | 0.56 | 31% | 33% | |
| Current ratioHigher is better · 335 reported | 1.62× | 2.82× | 25% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 2.6B USD | 100 | 43 | |
| 3 | 3.6B USD | 99 | ||
| 4 | 1.8B USD | 99 | 42 | |
| 5 | 2.2B USD | 99 | 48 | |
| 181 | 15.0B CNY (≈$2.1B) | 51 | 55 | |
| 182 | 31.3B CNY (≈$4.4B) | 50 | 65 | |
| 183 | 428.3B JPY (≈$2.9B) | 50 | 59 | |
| 184 | 12.2B CNY (≈$1.7B) | 50 | 39 | |
| 185 | 2.7B USD | 50 | 56 | |
| 186 | 3.01T KRW (≈$2.2B) | 50 | 53 | |
| 187 | 423.1B JPY (≈$2.9B) | 50 | 65 | |
| 188 | 2.4B USD | 49 | 64 | |
| 189 | 5.24T KRW (≈$3.8B) | 49 | 60 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score